Top latest Five BRD4-targeted therapy ABBV-744 clinical data Urban news
In Section C, individuals will receive ABBV-744 and oral navitoclax. In Section D, members will receive ABBV-744 and ruxolitinib. Individuals will get treatment till disease progression or perhaps the contributors are unable to tolerate the study drugs.Achievable new methods for the diagnosis and treatment of AML. (A) The identification of Tremendo